Saturday, November 23, 2024
HomeTagsDupixent Trial

Dupixent Trial

Second Positive Phase 3 Dupixent Trial Confirms Significant Improvements for Patients with Prurigo Nodularis

Regeneron Pharmaceuticals, Inc. and Sanofi announced positive pivotal results from a second Phase 3 trial, PRIME, evaluating Dupixent® (dupilumab) in adults with uncontrolled prurigo...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics